Recherche avancée

Le Dr Kenneth F. Buechler est président du conseil d'administration de Quidel Corp. et membre de l'American Association for Clinical Chemistry, de l'American Chemical Society, de l'International Federation of Clinical Chemistry & Lab Medicine et de la Biochemical Society. Il est membre du conseil d'administration de Sotera Wireless, Inc. et de TriVirum, Inc. Le Dr Buechler a été précédemment employé en tant que président du conseil d'administration de Sequenom, Inc, président et directeur scientifique de BioSite, Inc, président, directeur et directeur scientifique de New Biosite, Inc, et scientifique principal de Hybritech, Inc. Il a également siégé au conseil d'administration d'Adnavance Technologies, Inc, d'Astute Medical, Inc et d'Edico Genome Corp. Il a obtenu son diplôme de premier cycle à l'Université de l'Indiana et un doctorat à l'Université de l'Indiana.

William J.
Buechler is the founder of Buechler Capital Asset Management LLC, which was founded in 2006.
He held the title of President from 2011 to 2012.
Mr. Buechler received an undergraduate degree from San Diego State University in 1976.

Ying J.
Buechler is currently the Chief Technology Officer at Ambrx, Inc. Prior to this role, Buechler held positions at aTyr Pharma, Inc. as the Director-Protein Services, at Egen, Inc. as the Vice President-Development, at Canji, Inc. as a Scientist, and at Prizm Pharmaceuticals, Inc. as a Principal.
Buechler completed their undergraduate degree at Peking University and their doctorate degree at the University of California San Diego.

Michael Buechler is the founder of Linkbuddies.com LLC, which was founded in 1998.
He is currently working as a Product Director at Dun & Bradstreet Credibility Corp.
Mr. Buechler has previously worked as a Director-Product Strategy at Website Pros, Inc. from 2005 to 2008, as a Vice President-Web Properties at eBoz.com from 2001 to 2005, and as a Secretary & Director at American Battery Materials, Inc. from 2012 to 2014.